Literature DB >> 9405686

Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.

M Messerle1, I Crnkovic, W Hammerschmidt, H Ziegler, U H Koszinowski.   

Abstract

A strategy for cloning and mutagenesis of an infectious herpesvirus genome is described. The mouse cytomegalovirus genome was cloned and maintained as a 230 kb bacterial artificial chromosome (BAC) in E. coli. Transfection of the BAC plasmid into eukaryotic cells led to a productive virus infection. The feasibility to introduce targeted mutations into the BAC cloned virus genome was shown by mutation of the immediate-early 1 gene and generation of a mutant virus. Thus, the complete construction of a mutant herpesvirus genome can now be carried out in a controlled manner prior to the reconstitution of infectious progeny. The described approach should be generally applicable to the mutagenesis of genomes of other large DNA viruses.

Entities:  

Mesh:

Year:  1997        PMID: 9405686      PMCID: PMC25110          DOI: 10.1073/pnas.94.26.14759

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

Authors:  H Shizuya; B Birren; U J Kim; V Mancino; T Slepak; Y Tachiiri; M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Authors:  R R Spaete; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Manipulation of transgenes by site-specific recombination: use of Cre recombinase.

Authors:  B Sauer
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

5.  Stable propagation of cosmid sized human DNA inserts in an F factor based vector.

Authors:  U J Kim; H Shizuya; P J de Jong; B Birren; M I Simon
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

6.  Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene.

Authors:  D Wolff; G Jahn; B Plachter
Journal:  Gene       Date:  1993-08-25       Impact factor: 3.688

7.  Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3.

Authors:  M Messerle; B Bühler; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone.

Authors:  G Ketner; F Spencer; S Tugendreich; C Connelly; P Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

9.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

10.  Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain).

Authors:  J A Mercer; J R Marks; D H Spector
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

View more
  202 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome.

Authors:  F Almazán; J M González; Z Pénzes; A Izeta; E Calvo; J Plana-Durán; L Enjuanes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  The making of infectious viral RNA: No size limit in sight.

Authors:  M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents.

Authors:  M Marschall; M Freitag; S Weiler; G Sorg; T Stamminger
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis.

Authors:  G A Smith; L W Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

6.  In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus.

Authors:  N K Grzimek; J Podlech; H P Steffens; R Holtappels; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 7.  The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  Mol Pathol       Date:  2000-10

8.  The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth.

Authors:  A Angulo; P Ghazal; M Messerle
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth.

Authors:  Fabien Dorange; B Karsten Tischer; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.